Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (SYRS)

89 filings reported holding SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share as of Q2 2024.
Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (SYRS) has 70 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 20,382,905 shares of 27,196,692 outstanding shares and own 74.95% of the company stock.
Largest 10 shareholders include Bain Capital Life Sciences Investors, LLC (2,749,808 shares), Artal Group S.A. (2,505,013 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (2,071,914 shares), Samsara BioCapital, LLC (1,786,427 shares), Avidity Partners Management LP (1,673,538 shares), Point72 Asset Management, L.P. (1,471,771 shares), Flagship Pioneering Inc. (1,293,849 shares), VANGUARD GROUP INC (968,217 shares), Opaleye Management Inc. (865,443 shares), and Deep Track Capital, LP (828,485 shares).
This table shows the top 70 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.